Australia markets closed

Sangamo Therapeutics, Inc. (SGMO)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
0.6146-0.0350 (-5.39%)
At close: 04:00PM EDT
0.6199 +0.01 (+0.86%)
After hours: 07:48PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 127.54M
Enterprise value 103.94M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)5.81
Price/book (mrq)2.25
Enterprise value/revenue 5.54
Enterprise value/EBITDA -1.00

Trading information

Stock price history

Beta (5Y monthly) 1.40
52-week change 3-59.60%
S&P500 52-week change 328.04%
52-week high 31.6700
52-week low 30.2900
50-day moving average 30.6086
200-day moving average 30.6479

Share statistics

Avg vol (3-month) 32.01M
Avg vol (10-day) 32.79M
Shares outstanding 5207.51M
Implied shares outstanding 6207.51M
Float 8171.09M
% held by insiders 17.71%
% held by institutions 151.22%
Shares short (30 Apr 2024) 414.36M
Short ratio (30 Apr 2024) 49.6
Short % of float (30 Apr 2024) 46.96%
Short % of shares outstanding (30 Apr 2024) 46.92%
Shares short (prior month 28 Mar 2024) 411.41M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)-9,621.00%

Management effectiveness

Return on assets (ttm)-49.47%
Return on equity (ttm)-167.24%

Income statement

Revenue (ttm)18.76M
Revenue per share (ttm)0.11
Quarterly revenue growth (yoy)-99.70%
Gross profit (ttm)N/A
EBITDA -212.39M
Net income avi to common (ttm)-328.05M
Diluted EPS (ttm)-1.8800
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)54.42M
Total cash per share (mrq)0.26
Total debt (mrq)30.82M
Total debt/equity (mrq)54.35%
Current ratio (mrq)1.71
Book value per share (mrq)0.28

Cash flow statement

Operating cash flow (ttm)-207.2M
Levered free cash flow (ttm)-120.99M